ZEPBOUND (tirzepatide)
2.5 mg/.5mL · Injection Solution
By Eli Lilly and Company
- NDC
- 0002-2506
- Route
- Subcutaneous
- Therapeutic class
- G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist , Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- Marketing category
- NDA
Package sizes
- 4 SYRINGE in 1 CARTON (0002-2506-61) / .5 mL in 1 SYRINGENDC 0002-2506-61Available to order
- 4 SYRINGE in 1 CARTON (0002-2506-80) / .5 mL in 1 SYRINGE (0002-2506-01)NDC 0002-2506-80Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Diabetes & Endocrine
See all →
OMEOSPORT
Pellet
Guna spa
Available to source
GUNA-GERIATRICS
Solution / Drops
Guna spa
Available to source
PROCORT (1.85% hydrocortisone acetate - 1.15% pramoxine hci cream)
18.5 mg/g / 11.5 mg/g · Cream
Womens Choice Pharmaceuticals LLC
Available to source
Equate Hydrocortione (1% Hydrocortisone)
10 mg/g · Cream
Walmart Inc.
Available to source